Modeling of electric field distribution in tissues during electroporation

BackgroundElectroporation based therapies and treatments (e.g. electrochemotherapy, gene electrotransfer for gene therapy and DNA vaccination, tissue ablation with irreversible electroporation and transdermal drug delivery) require a precise prediction of the therapy or treatment outcome by a personalized treatment planning procedure. Numerical modeling of local electric field distribution within electroporated tissues has become an important tool in treatment planning procedure in both clinical and experimental settings. Recent studies have reported that the uncertainties in electrical properties (i.e. electric conductivity of the treated tissues and the rate of increase in electric conductivity due to electroporation) predefined in numerical models have large effect on electroporation based therapy and treatment effectiveness. The aim of our study was to investigate whether the increase in electric conductivity of tissues needs to be taken into account when modeling tissue response to the electroporation pulses and how it affects the local electric distribution within electroporated tissues.MethodsWe built 3D numerical models for single tissue (one type of tissue, e.g. liver) and composite tissue (several types of tissues, e.g. subcutaneous tumor). Our computer simulations were performed by using three different modeling approaches that are based on finite element method: inverse analysis, nonlinear parametric and sequential analysis. We compared linear (i.e. tissue conductivity is constant) model and non-linear (i.e. tissue conductivity is electric field dependent) model. By calculating goodness of fit measure we compared the results of our numerical simulations to the results of in vivo measurements.ResultsThe results of our study show that the nonlinear models (i.e. tissue conductivity is electric field dependent: σ(E)) fit experimental data better than linear models (i.e. tissue conductivity is constant). This was found for both single tissue and composite tissue. Our results of electric field distribution modeling in linear model of composite tissue (i.e. in the subcutaneous tumor model that do not take into account the relationship σ(E)) showed that a very high electric field (above irreversible threshold value) was concentrated only in the stratum corneum while the target tumor tissue was not successfully treated. Furthermore, the calculated volume of the target tumor tissue exposed to the electric field above reversible threshold in the subcutaneous model was zero assuming constant conductivities of each tissue.Our results also show that the inverse analysis allows for identification of both baseline tissue conductivity (i.e. conductivity of non-electroporated tissue) and tissue conductivity vs. electric field (σ(E)) of electroporated tissue.ConclusionOur results of modeling of electric field distribution in tissues during electroporation show that the changes in electrical conductivity due to electroporation need to be taken into account when an electroporation based treatment is planned or investigated. We concluded that the model of electric field distribution that takes into account the increase in electric conductivity due to electroporation yields more precise prediction of successfully electroporated target tissue volume. The findings of our study can significantly contribute to the current development of individualized patient-specific electroporation based treatment planning.

[1]  W. Swoboda,et al.  Molecular monitoring of inactivation efficiencies of bacteria during pulsed electric field treatment of clinical wastewater , 2008, Journal of applied microbiology.

[2]  E. Neumann,et al.  Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.

[3]  B. Rubinsky,et al.  Tissue Ablation with Irreversible Electroporation , 2005, Annals of Biomedical Engineering.

[4]  L. Mir Bases and rationale of the electrochemotherapy , 2006 .

[5]  Francesco Cavani,et al.  Cell Electroporation in Bone Tissue , 2011 .

[6]  Damijan Miklavcic,et al.  Equivalent Pulse Parameters for Electroporation , 2011, IEEE Transactions on Biomedical Engineering.

[7]  Damijan Miklavcic,et al.  A Numerical Model of Permeabilized Skin With Local Transport Regions , 2008, IEEE Transactions on Biomedical Engineering.

[8]  T. Jarm,et al.  Electrochemotherapy , 2011, Technology in cancer research & treatment.

[9]  A. Zupanic,et al.  Numerical Modeling and Optimization of Electric Field Distribution in Subcutaneous Tumor Treated With Electrochemotherapy Using Needle Electrodes , 2008, IEEE Transactions on Plasma Science.

[10]  Damijan Miklavčič,et al.  Patient-specific treatment planning of electrochemotherapy: procedure design and possible pitfalls. , 2012, Bioelectrochemistry.

[11]  G. Pucihar,et al.  Numerical Determination of Transmembrane Voltage Induced on Irregularly Shaped Cells , 2006, Annals of Biomedical Engineering.

[12]  Boris Rubinsky,et al.  Tumor Ablation with Irreversible Electroporation , 2007, PloS one.

[13]  Faisal Mahmood,et al.  Optimizing clinical performance and geometrical robustness of a new electrode device for intracranial tumor electroporation. , 2011, Bioelectrochemistry.

[14]  Tomaz Slivnik,et al.  Sequential finite element model of tissue electropermeabilization , 2005, IEEE Transactions on Biomedical Engineering.

[15]  Y. Glinka,et al.  Electroporation-enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases. , 2006, Current gene therapy.

[16]  Silvia Giavazzi,et al.  Inverse determination of viscoelastic properties of human fingertip skin Inverzno določanje viskoelastičnih lastnosti človeške kože na prstu , 2010 .

[17]  Damijan Miklavčič,et al.  Optimization and Numerical Modeling in Irreversible Electroporation Treatment Planning , 2010 .

[18]  V. Sondak,et al.  Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Mojca Pavlin,et al.  A numerical analysis of multicellular environment for modeling tissue electroporation , 2012 .

[20]  Damijan Miklavčič,et al.  Induced Transmembrane Voltage and Its Correlation with Electroporation-Mediated Molecular Transport , 2010, The Journal of Membrane Biology.

[21]  Julie Gehl,et al.  Clinical aspects of electroporation , 2011 .

[22]  Tanja Cufer,et al.  Electrochemotherapy of chest wall breast cancer recurrence. , 2012, Cancer treatment reviews.

[23]  Damijan Miklavčič,et al.  Optimization of electrode position and electric pulse amplitude in electrochemotherapy , 2008 .

[24]  Mojca Pavlin,et al.  Analytical and numerical quantification and comparison of the local electric field in the tissue for different electrode configurations , 2007, Biomedical engineering online.

[25]  Dieter Haemmerich,et al.  In vivo electrical conductivity of hepatic tumours. , 2003, Physiological measurement.

[26]  D. Miklavčič,et al.  Incorporating Electroporation-related Conductivity Changes into Models for the Calculation of the Electric Field Distribution in Tissue , 2010 .

[27]  T. L. Ellis,et al.  Non-Thermal Irreversible Electroporation (N-TIRE) and Adjuvant Fractionated Radiotherapeutic Multimodal Therapy for Intracranial Malignant Glioma in a Canine Patient , 2011, Technology in cancer research & treatment.

[28]  M. Morales-de la Peña,et al.  Food Preservation by Pulsed Electric Fields: An Engineering Perspective , 2011 .

[29]  Damijan Miklavčič,et al.  In Vivo Muscle Electroporation Threshold Determination: Realistic Numerical Models and In Vivo Experiments , 2012, The Journal of Membrane Biology.

[30]  Richard Heller,et al.  Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  Faisal Mahmood,et al.  Preclinical validation of electrochemotherapy as an effective treatment for brain tumors. , 2011, Cancer research.

[32]  Rafael V. Davalos,et al.  Intracranial Nonthermal Irreversible Electroporation: In Vivo Analysis , 2010, The Journal of Membrane Biology.

[33]  J. Gehl,et al.  Management of cutaneous metastases using electrochemotherapy , 2011, Acta oncologica.

[34]  Eugène Vorobiev,et al.  Electrotechnologies for extraction from food plants and biomaterials , 2008 .

[35]  Rafael V. Davalos,et al.  Successful treatment of a large soft tissue sarcoma with irreversible electroporation. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  Tadej Kotnik,et al.  Sensitivity of transmembrane voltage induced by applied electric fields—A theoretical analysis , 1997 .

[37]  B. Benway Irreversible Electroporation of Renal Cell Carcinoma: A First-in-Man Phase I Clinical Study: Pech M, Janitzky A, Wendler JJ, et al (Univ of Magdeburg, Germany) Cardiovasc Intervent Radiol 34:132-138, 2011§ , 2011 .

[38]  C. Gabriel,et al.  Electrical conductivity of tissue at frequencies below 1 MHz , 2009, Physics in medicine and biology.

[39]  A. Testori,et al.  Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach , 2010, Dermatologic therapy.

[40]  Mojca Pavlin,et al.  Effect of cell electroporation on the conductivity of a cell suspension. , 2005, Biophysical journal.

[41]  Damijan Miklavcic,et al.  Robustness of Treatment Planning for Electrochemotherapy of Deep-Seated Tumors , 2010, The Journal of Membrane Biology.

[42]  L. Mir,et al.  Use of conductive gels for electric field homogenization increases the antitumor efficacy of electroporation therapies , 2008, Physics in medicine and biology.

[43]  S. Mocellin,et al.  Electrochemotherapy for disseminated superficial metastases from malignant melanoma , 2012, The British journal of surgery.

[44]  D. Miklavčič,et al.  Effect of Electric-Field Intensity on Electropermeabilization and Electrosensitmty of Various Tumor-Cell Lines In Vitro , 1998 .

[45]  D Miklavcic,et al.  The importance of electric field distribution for effective in vivo electroporation of tissues. , 1998, Biophysical journal.

[46]  Jože Korelc,et al.  Automation of primal and sensitivity analysis of transient coupled problems , 2009 .

[47]  D Miklavcic,et al.  A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. , 2000, Biochimica et biophysica acta.

[48]  J Teissié,et al.  Electropermeabilization of mammalian cells. Quantitative analysis of the phenomenon. , 1990, Biophysical journal.

[49]  Jens Ricke,et al.  Irreversible Electroporation of Renal Cell Carcinoma: A First-in-Man Phase I Clinical Study , 2011, CardioVascular and Interventional Radiology.

[50]  D Miklavcic,et al.  Electrochemotherapy in veterinary oncology. , 2008, Journal of Veterinary Internal Medicine.

[51]  Damijan Miklavcic,et al.  Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy , 2010, Biomedical engineering online.

[52]  Damijan Miklavcic,et al.  The course of tissue permeabilization studied on a mathematical model of a subcutaneous tumor in small animals , 2005, IEEE Transactions on Biomedical Engineering.

[53]  P. Sweeney,et al.  Optimised electroporation mediated DNA vaccination for treatment of prostate cancer , 2010, Genetic vaccines and therapy.

[54]  J Teissié,et al.  An experimental evaluation of the critical potential difference inducing cell membrane electropermeabilization. , 1993, Biophysical journal.

[55]  Boris Rubinsky,et al.  Irreversible Electroporation: First Patient Experience Focal Therapy of Prostate Cancer , 2010 .

[56]  Antonella Vecchiato,et al.  Bleomycin-Based Electrochemotherapy: Clinical Outcome from a Single Institution’s Experience with 52 Patients , 2008, Annals of Surgical Oncology.

[57]  M. Čemažar,et al.  Cancer electrogene therapy with interleukin-12. , 2010, Current gene therapy.

[58]  P. Capasso,et al.  Electrochemotherapy for Non-Melanoma Head and Neck Cancers: Clinical Outcomes in 25 Patients , 2012, Annals of surgery.

[59]  Richard Heller,et al.  Electroporation gene therapy preclinical and clinical trials for melanoma. , 2010, Current gene therapy.

[60]  L. Mir,et al.  Importance of Contact Surface between Electrodes and Treated Tissue in Electrochemotherapy , 2008, Technology in cancer research & treatment.

[61]  Mojca Pavlin,et al.  Effect of electric field induced transmembrane potential on spheroidal cells: theory and experiment , 2003, European Biophysics Journal.

[62]  Boris Rubinsky,et al.  Optimal parameters for the destruction of prostate cancer using irreversible electroporation. , 2008, The Journal of urology.

[63]  Rafael V. Davalos,et al.  Experimental Characterization and Numerical Modeling of Tissue Electrical Conductivity during Pulsed Electric Fields for Irreversible Electroporation Treatment Planning , 2012, IEEE Transactions on Biomedical Engineering.

[64]  Damijan Miklavcic,et al.  Treatment planning of electroporation-based medical interventions: electrochemotherapy, gene electrotransfer and irreversible electroporation , 2012, Physics in medicine and biology.

[65]  Damijan Miklavcic,et al.  Real time electroporation control for accurate and safe in vivo non-viral gene therapy. , 2007, Bioelectrochemistry.

[66]  Damijan Miklavcic,et al.  The influence of skeletal muscle anisotropy on electroporation: in vivo study and numerical modeling , 2010, Medical & Biological Engineering & Computing.

[67]  Mojca Pavlin,et al.  Numerical optimization of gene electrotransfer into muscle tissue , 2010, Biomedical engineering online.

[68]  Wolfgang Frey,et al.  Research on Industrial-Scale Electroporation Devices Fostering the Extraction of Substances from Biological Tissue , 2010 .

[69]  Damijan Miklavčič,et al.  Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy , 2006 .